Related Experiment Videos
Factor V Leiden and perioperative risk.
1Department of Anesthesiology, Vanderbilt University, Nashville, Tennessee.
Anesthesia and Analgesia
|May 25, 2004
Summary
Factor V Leiden (FVL) increases thrombophilia risk. This review explores FVL
Area of Science:
- Medical Genetics
- Hematology
- Surgical Risk Assessment
Background:
- Factor V Leiden (FVL) is the most prevalent inherited thrombophilia, affecting ~5% of Caucasians.
- Perioperative thrombotic and hemorrhagic risks associated with FVL are not well-established.
- Limited research exists on FVL's impact in the surgical population, necessitating comprehensive review.
Purpose of the Study:
- To review the physiology of the Factor V Leiden mutation.
- To summarize FVL's risk in non-surgical contexts.
- To assess current data on FVL in cardiac and noncardiac surgery.
Main Methods:
- Literature review and synthesis of existing studies.
- Analysis of physiological mechanisms of FVL.
- Evaluation of clinical data on FVL in surgical patients.
Main Results:
- FVL is a significant inherited risk factor for venous thrombosis.
- Existing data on perioperative FVL risk is limited but growing.
- Further investigation is needed to fully understand FVL's role in surgical complications.
Conclusions:
- Factor V Leiden poses a potential, yet understudied, perioperative risk.
- Comprehensive investigation into FVL's impact on surgical outcomes is warranted.
- Evidence-based guidelines are needed for managing FVL in surgical patients.